News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
672,886 Results
Type
Article (56112)
Company Profile (161)
Press Release (616598)
Multimedia
Podcasts (180)
Webinars (23)
Section
Business (177772)
Career Advice (2533)
Deals (32612)
Drug Delivery (165)
Drug Development (76689)
Employer Resources (168)
FDA (17508)
Job Trends (14318)
News (314314)
Policy (33881)
Tag
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2727)
Academic (1)
Accelerated approval (52)
Adcomms (40)
Allergies (177)
Alliances (44611)
ALS (216)
Alzheimer's disease (1889)
Antibody-drug conjugate (ADC) (491)
Approvals (17809)
Artificial intelligence (711)
Autoimmune disease (310)
Automation (51)
Bankruptcy (338)
Best Places to Work (10836)
BIOSECURE Act (23)
Biosimilars (234)
Biotechnology (98)
Bladder cancer (203)
Brain cancer (77)
Breast cancer (756)
Cancer (5935)
Cardiovascular disease (518)
Career advice (2162)
Career pathing (47)
CAR-T (327)
CDC (75)
Celiac Disease (3)
Cell therapy (922)
Cervical cancer (49)
Clinical research (67005)
Collaboration (2014)
Company closure (7)
Compensation (1423)
Complete response letters (102)
COVID-19 (2900)
CRISPR (111)
C-suite (1147)
Cystic fibrosis (159)
Data (7907)
Decentralized trials (3)
Denatured (52)
Depression (184)
Dermatology (91)
Diabetes (597)
Diagnostics (6560)
Digital health (53)
Diversity (10)
Diversity, equity & inclusion (43)
Drug discovery (309)
Drug pricing (240)
Drug shortages (36)
Duchenne muscular dystrophy (302)
Earnings (74218)
Editorial (77)
Employer branding (20)
Employer resources (149)
Events (101509)
Executive appointments (1102)
FDA (21370)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1697)
Gene editing (243)
Generative AI (63)
Gene therapy (761)
GLP-1 (1198)
Government (4818)
Grass and pollen (8)
Guidances (407)
Healthcare (18558)
HIV (83)
Huntington's disease (60)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (340)
Immuno-oncology (95)
Indications (191)
Infectious disease (3252)
Inflammatory bowel disease (223)
Inflation Reduction Act (15)
Influenza (130)
Intellectual property (286)
Interviews (463)
IPO (15479)
IRA (58)
Job creations (3777)
Job search strategy (1767)
JPM (70)
Kidney cancer (21)
Labor market (102)
Layoffs (658)
Leadership (50)
Legal (7979)
Liver cancer (107)
Longevity (29)
Lung cancer (792)
Lymphoma (427)
Machine learning (59)
Management (57)
Manufacturing (1039)
MASH (204)
Medical device (14702)
Medtech (14832)
Mergers & acquisitions (18372)
Metabolic disorders (1641)
mRNA (237)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (448)
Neuropsychiatric disorders (122)
Neuroscience (3460)
Neurotech (2)
NextGen: Class of 2026 (6241)
Non-profit (4239)
Now hiring (57)
Obesity (808)
Opinion (316)
Ovarian cancer (215)
Pain (271)
Pancreatic cancer (309)
Parkinson's disease (373)
Partnered (29)
Patents (598)
Patient recruitment (697)
Peanut (61)
People (55939)
Pharmaceutical (42)
Pharmacy benefit managers (36)
Phase 1 (20342)
Phase 2 (29282)
Phase 3 (22842)
Pipeline (8825)
Policy (383)
Postmarket research (2619)
Preclinical (8235)
Press Release (38)
Prostate cancer (320)
Psychedelics (66)
Radiopharmaceuticals (323)
Rare diseases (1186)
Real estate (5454)
Recruiting (68)
Regulatory (26838)
Reports (48)
Research institute (2491)
Resumes & cover letters (416)
Rett syndrome (39)
RNA editing (25)
RSV (92)
Schizophrenia (190)
Series A (287)
Series B (214)
Service/supplier (9)
Sickle cell disease (117)
Special edition (30)
Spinal muscular atrophy (167)
Sponsored (52)
Startups (3474)
State (1)
Stomach cancer (21)
Supply chain (132)
Tariffs (104)
The Weekly (126)
Vaccines (1215)
Venture capital (122)
Weight loss (564)
Women's health (121)
Worklife (24)
Date
Today (5)
Last 7 days (509)
Last 30 days (3255)
Last 365 days (30025)
2026 (13056)
2025 (30213)
2024 (34340)
2023 (38601)
2022 (49587)
2021 (53777)
2020 (52009)
2019 (43965)
2018 (33366)
2017 (31880)
2016 (30813)
2015 (34551)
2014 (27793)
2013 (23155)
2012 (24893)
2011 (25220)
2010 (23459)
Location
Africa (818)
Alabama (87)
Alaska (6)
Arizona (326)
Arkansas (15)
Asia (40610)
Australia (6812)
California (12996)
Canada (3350)
China (1364)
Colorado (540)
Connecticut (578)
Delaware (399)
Europe (92588)
Florida (1991)
Georgia (433)
Hawaii (4)
Idaho (56)
Illinois (1069)
India (84)
Indiana (562)
Iowa (23)
Japan (550)
Kansas (123)
Kentucky (50)
Louisiana (39)
Maine (81)
Maryland (1574)
Massachusetts (9372)
Michigan (340)
Minnesota (705)
Mississippi (7)
Missouri (142)
Montana (24)
Nebraska (26)
Nevada (140)
New Hampshire (84)
New Jersey (3477)
New Mexico (20)
New York (3392)
North Carolina (1697)
North Dakota (10)
Northern California (6553)
Ohio (383)
Oklahoma (22)
Oregon (40)
Pennsylvania (2530)
Puerto Rico (24)
Rhode Island (44)
South America (1192)
South Carolina (85)
South Dakota (2)
Southern California (5150)
Tennessee (207)
Texas (2074)
United States (46002)
Utah (361)
Virginia (328)
Washington D.C. (81)
Washington State (1042)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
672,886 Results for "palex medical s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Biovica Signs Agreement with Palex Group, a Market Leader in Spain and Portugal
Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, has signed a collaboration agreement for DiviTum® TKa in Spain and Portugal with the Palex Group, a leading hospital equipment supplier with a proven track record in taking oncology tests and surgical instruments to market in southern Europe.
January 19, 2024
·
3 min read
Press Releases
Adagio Medical’s ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference
April 17, 2026
·
4 min read
Press Releases
Vistagen Appoints Angel S. Angelov, MD, MBA, as Chief Medical Officer
May 19, 2026
·
5 min read
Press Releases
EuroPCR 2026: Elixir Medical’s DynamX® Bioadaptor Demonstrates Significantly Lower Event Rates Than Drug-Eluting Stent
May 19, 2026
·
6 min read
Press Releases
Veristat to Acquire Certara’s Regulatory and Medical Writing Business
April 22, 2026
·
2 min read
Press Releases
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
May 20, 2026
·
1 min read
Press Releases
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
March 26, 2026
·
6 min read
Press Releases
Bracco and ACIST Medical Systems Announce U.S. FDA Clearance of ACIST Pro™ Diagnostic System
May 18, 2026
·
5 min read
Press Releases
TempraMed Featured on Dr. Phil Show in National US Broadcast Highlighting the Risk of Temperature Exposure for Insulin and Other Medications
Broadcast across the United States brings attention to the under-addressed risk of medication degradation caused by heat exposure and the real-world need for better medication protection and tracking
May 22, 2026
·
4 min read
Immunology and inflammation
AbbVie’s new immunology standard-bearer Skyrizi kneels to UCB’s Bimzelx in psoriatic arthritis
UCB’s Bimzelx elicited significantly stronger joint relief at 16 weeks than AbbVie’s Skyrizi in a Phase 3 head-to-head study of psoriatic arthritis.
May 20, 2026
·
2 min read
·
Tristan Manalac
1 of 67,289
Next
